MCC950, an NLRP3-specific inhibitor directly blocking the NACHT domain [169, 170], significantly alleviates systemic LPS-induced HL in CAPS-associated NLRP3 mutant mice [165]. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.